The Indiana CTSI Molecular Therapeutics Program (MTP) utilizes the Indiana Drug Discovery Alliance (IDDA), a cross-state drug discovery consortium, to promote and support promising early stage drug discovery research.
We support investigators by:
- Acting as a clearinghouse for drug discovery & developmental resources throughout the Midwest
- Facilitating compound library sharing & collaborative, translational research between scientists/researchers
- Identifying complimentary, support, and external partnerships
- Funding early-stage drug discovery not traditionally covered by our other Indiana CTSI Service Cores Grants
MTP also supports drug development services to promote the use of contract research organizations that offer ADME-toxicology studies for lead compounds. CRO partnerships include Covance Inc., Q2 solutions, Albany Molecular Research Inc., CalChem Synthesis, Bio reliance, and Eurofins.